5/24/2023 0 Comments Methods for treating myocardial infarction comprising adminis... by Alain LacampagneSuch infarcted area lacks contractility, and fails to withstand the intracardiac pressure that rises with cardiac contraction, and then the fibrous wall extends thinly. The expansion and/or deterioration of infarcted area cause complications such as heart failure and/or ischemia-induced severe arrhythmia, and increase threat to life.Īs myocardial infarction progresses, myocardial cells in infarcted areas die and/or slough off, and are displaced with fibrous tissues such as collagen fiber. It is a disorder that causes myocardial necrosis where constriction of cardiac coronary artery occurs due to arteriosclerosis and such, and the bloodstream of the coronary artery becomes dramatically reduced or stopped. Myocardial infarction is one of ischemic heart diseases. Furthermore, the present invention relates to agents for suppressing left ventricular remodeling after myocardial infarction, which comprise an IL-6 inhibitor as an active ingredient and uses thereof. The present invention relates to agents for treating myocardial infarction which comprise an IL-6 inhibitor as an active ingredient and uses thereof. The contents of both of the foregoing applications are hereby incorporated by reference in their entirety. 20, 2006, which claims the benefit of Japanese Application Serial No. This application is the National Stage of International Application Serial No.
0 Comments
Leave a Reply. |